INCEPTOR BIO
Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers, with a focus on novel mechanisms to improve immune cell performance in the tumor microenvironment. Inceptor Bio provides a partnership model to university research programs focused on cutting-edge therapeutic approaches for oncology. The combination of their lab and manufacturing resources with the industry experience of their cell and gene therapy experts will advance therapeutics into the clinic with remarkable efficiency.
INCEPTOR BIO
Industry:
Biotechnology Health Care Wellness
Founded:
2020-01-01
Address:
Raleigh, North Carolina, United States
Country:
United States
Website Url:
http://www.inceptor.bio
Total Employee:
1+
Status:
Active
Contact:
(919) 521-6400
Total Funding:
71.77 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Amazon Microsoft Azure DNS Cloudflare JS CDN JS GoDaddy DNS
Similar Organizations
HebeCell
HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases.
Pandion Therapeutics
Pandion Therapeutics develops innovative modular proteins, antibodies, and bispecifics for autoimmune and inflammatory diseases.
Phyla
Phyla is developing alternative therapies for antibiotics.
Providence Therapeutics
Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat ovarian cancer.
Current Advisors List
Advisor
2021-06-01
Current Employees Featured
Derek Hennecke Partner @ Inceptor Bio
Partner
2017-07-01
Abe Maingi VP, Business Development, Board of Directors, Co-Founder @ Inceptor Bio
VP, Business Development, Board of Directors, Co-Founder
2020-08-01
Shailesh Maingi Founder and CEO @ Inceptor Bio
Founder and CEO
2020-01-01
Founder
Investors List
Kineticos Ventures
Kineticos Ventures investment in Series A - Inceptor Bio
Kineticos Disruptor Fund
Kineticos Disruptor Fund investment in Seed Round - Inceptor Bio
Official Site Inspections
http://www.inceptor.bio Semrush global rank: 3.67 M Semrush visits lastest month: 3.82 K
- Host name: 73.133.208.35.bc.googleusercontent.com
- IP address: 35.208.133.73
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Inceptor Bio"
About Us - Inceptor Bio
Jason Lawrence is Vice President of Finance at Inceptor Bio, overseeing the company’s accounting, tax, treasury, and financial planning functions. Prior to joining Inceptor Bio, he was …See details»
Inceptor Bio - Crunchbase Company Profile & Funding
Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers, with a focus on novel mechanisms to improve immune cell performance in the tumor microenvironment. Inceptor Bio …See details»
Inceptor Bio and GRIT Bio Announce Strategic Partnership to …
Dec 18, 2024 About Inceptor Bio. Inceptor Bio, founded in May 2020 and headquartered in Research Triangle Park, NC, is dedicated to advancing next-generation cell and gene …See details»
Inceptor Bio - LinkedIn
Inceptor Bio is a clinical-stage biotech company pioneering next-generation cell therapies to cure cancer. Our proprietary OUTLAST™ platform reprograms T cells into persistent, stem-like cells ...See details»
Inceptor Bio LLC - Drug pipelines, Patents, Clinical trials …
About Inceptor Bio Inceptor Bio, founded in May 2020 and headquartered in Research Triangle Park, NC, is dedicated to advancing next-generation cell and gene therapies to cure cancer. Inceptor's lead program, IB-T101, targets …See details»
Inceptor Bio Snags $37M for Three-Pronged Immuno-Oncology …
May 20, 2022 Inceptor Bio CEO Shailesh Maingi/Courtesy of Inceptor Bio. Fueled by $37 million in Series A financing, N.C.-based Inceptor Bio is advancing three next-generation approaches …See details»
Kineticos Portfolio Company, Inceptor Bio, Announces First Patient ...
Research Triangle Park, NC – Inceptor Bio, a clinical-stage biotechnology company pioneering next-generation cell therapies, today announced that the first patient has been dosed in the …See details»
Inceptor Bio Announces Agreement to Acquire Gainesville, FL GMP ...
Oct 27, 2021 Inceptor Bio's Advanced Manufacturing Platform (AMP+) will be based at the new facility in Gainesville, FL, that will be developed as a state-of-the-art cell and gene therapy …See details»
Inceptor Bio Announces Agreement to Acquire …
Oct 27, 2021 Additional information about Inceptor Bio is available at www.inceptor.bio. About Arranta Bio Founded in 2019, Arranta Bio is a visionary contract development and manufacturing organization (CDMO) that partners …See details»
Inceptor Bio Announces First Patient Dosed in Clinical
Feb 25, 2025 Inceptor Bio, founded in May 2020 and headquartered in Research Triangle Park, NC, is dedicated to advancing next-generation cell and gene therapies to cure cancer. …See details»
Inceptor Bio doses first patient in cancer trial, raises $21M
Feb 27, 2025 Inceptor Bio, a cell therapy company based in Morrisville, has dosed the first patient in a clinical trial of its potential treatment for a type of kidney cancer. To help fund the …See details»
Inceptor Bio and GRIT Bio Cooperate to Advance IB-T101, a Next ...
Dec 18, 2024 IB-T101, Inceptor Bio's autologous CD70 CAR-T program, utilizes the proprietary OUTLAST™ platform to reprogram T cells for superior stemness, durability, and effector …See details»
Inceptor Bio to use $37M series A to nudge CAR-T into clinic
May 19, 2022 Inceptor Bio will use proceeds from a $37 million series A round to push its lead CAR-T program into phase 1 trials in 2023 and set up manufacturing capability in Florida.See details»
About Inceptor Bio
Jun 14, 2021 Inceptor Bio has also launched a new website at www.inceptor.bio to provide information on the company’s vision and activities. About Inceptor Bio. Founded in 2020, …See details»
Inceptor Bio and Avectas Announce Collaboration to Improve ...
Oct 12, 2022 For Inceptor Bio Abe Maingi [email protected] For Avectas. International Sue Charles, Charles Consultants +44 7968 726585 sue@charles-consultants,com. Ireland Ray …See details»
Inceptor Bio Enters into In-licensing Agreement with University of ...
Dec 16, 2021 About Inceptor Bio Founded in 2020, Inceptor Bio is a biotechnology company developing multiple next-generation cell and gene therapy platforms to deliver cures for …See details»
Inceptor Bio and Avectas partner for CAR-T cell therapies …
Oct 13, 2022 Inceptor Bio and Avectas hope that the combination of Solupore delivery with Inceptor’s CAR-T platform will boost performance and efficacy. Inceptor Bio founder and CEO …See details»
Inceptor Bio Announces $37 Million Series A Financing
May 19, 2022 Founded in 2020, Inceptor Bio is a biotechnology company developing multiple next-generation cell and gene therapy platforms to deliver cures for underserved and difficult …See details»
Establishing Canada’s first large-scale bioinnovation centre
2 days ago Today, the Honourable Darren Fisher, Member of Parliament for Dartmouth – Cole Harbour, announced a $5 million, non-repayable contribution to Neptune BioInnovation Inc. to …See details»
Inceptor Bio Announces First Patient Dosed in Clinical Trial of IB …
Feb 25, 2025 Research Triangle Park, NC – Inceptor Bio, a clinical-stage biotechnology company pioneering next-generation cell therapies, today announced that the first patient has …See details»